The Canadian HBV Network is committed to advancing Hepatitis B patient care, research and education. Through this, we hope to improve quality of life and long-term health outcomes for HBV patients in Canada and worldwide.
In October 2020 the Hepatitis B Foundation released its final report on the externally led patient- focused drug development meeting for hepatitis B, that they hosted in June 2020. The 55-page report, along with a link to the official video recording of the meeting, a complete transcript of the meeting and more than 300 email comments that were submitted can be found on their website (link here). This meeting was an opportunity for patients to discuss the significant physical and emotional impact of living with hepatitis B, as well as major challenges with current treatment.